GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 80 Rue Des Meuniers, Bagneux,paris Area 92220,france
- Phone
- 33(0)155-422-929
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- genomicvision.com
- Keywords
- Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule.
- HQ
- Bagneux, Paris Area
Genomic Vision Questions
Genomic Vision's helpline number is 33(0)155-422-929
Genomic Vision's website is genomicvision.com
Genomic Vision's LinkedIn profile is https://fr.linkedin.com/company/genomicvision
Genomic Vision has
13 employees.
View email and phone details for 13
employees at Genomic Vision.
Genomic Vision's industry is
Biotechnology Research
Genomic Vision's top competitors are
Stilla Technologies,
Endodiag,
Riveladx,
Integragen,
Oncovita,
Scipio Bioscience,
Abivax,
Whitelab Genomics,
Cellintel,
Cellectis.
Genomic Vision's categories are Biotechnology Research
Genomic Vision's founding year is 2005
